Skip to content

Condition: Post with Page_List

Listen
Search
Please enter at least 3 characters.

Latest Stories

Dallas startup Warhound raises $200 million for gene-edited military dogs

A Texas-based startup conceived by Colossal Biosciences co-founder Ben Lamm and Anduril founder Palmer Luckey has emerged from stealth with $200 million in seed funding to clone and genetically edit elite working dogs for the U.S. military, law enforcement, and emergency responders.

A Texas-based startup conceived by Colossal Biosciences co-founder Ben Lamm and Anduril founder Palmer Luckey has emerged from stealth with $200 million in seed funding to clone and genetically edit elite working dogs for the U.S. military, law enforcement, and emergency responders.

Getty Images


A Texas-based startup conceived by Colossal Biosciences co-founder Ben Lamm and Anduril founder Palmer Luckey has emerged from stealth with $200 million in seed funding to clone and genetically edit elite working dogs for the U.S. military, law enforcement, and emergency responders.

Warhound, valued at $1.2 billion, aims to rebuild a domestic supply of healthier, higher-performing canines and reduce the country’s long reliance on European breeders. According to the company’s announcement, more than 80 percent of U.S. military working dogs currently come from Europe, and fewer than half of those animals ultimately qualify for service after a multi-year procurement and training process. That means the Pentagon effectively sources and trains roughly 200 dogs to field 100 working animals.

TechCrunch reported that Lamm and Luckey developed the concept after meeting at a conference roughly a year ago. Lamm’s team has already collected cell lines from top-performing U.S. working dogs—primarily Belgian Malinois and German Shepherds, with some Labrador retrievers—and stored them in a biobank. Initial gene-editing efforts will focus on removing predispositions to common career-ending conditions such as hip dysplasia, certain cancers, and muscle atrophy. Later work could target enhancements in speed, agility, or scent detection. The first puppies are expected in early 2027, with the goal of having animals ready for service within about two years.

Cloning will be handled through Viagen, a Colossal-owned company with experience in animal cloning for conservation work. Anduril will supply external protective gear—including body armor, eye and ear protection, and situational-awareness tools—rather than implanted devices. “On top of the dog, not in the dog,” Lamm has emphasized. David Spirk, a former Marine and the Pentagon’s first chief data officer, serves as CEO. Investors include Sequoia Capital, In-Q-Tel (the CIA’s venture arm), ARK Invest, and others. The company says it is working with the American Humane Society to certify its training programs and support retirement placements for the dogs.

No animals have yet been born under the program, and no government contracts have been announced. Warhound is based in Texas, with Colossal providing the genetics and biobanking technology under license.

LISTEN on the Audacy App
Tell your Smart Speaker to "PLAY 1080 KRLD"
Sign Up to receive our KRLD Insider Newsletter for more news
Follow us on Facebook | Twitter | Instagram | YouTube